| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.0005 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |